Virinchi Share Price

Virinchi Limited was originally incorporated on 13 March, 1990 as a Private Limited Company with the name Vrinchi Consultants Limited. The Company changed the name from Vrinchi Consultants Limited to Vrinchi Technologies Limited on October 08, 2003. The Company was subsequently converted into a Public Limited Company on January 22, 2000 and during the year 201516, the name of the Company got changed from Virinchi Technologies Limited to Virinchi Limited. The Company received the Certificate of Incorporation on 12th January, 2016.Promoted by Viswanath Kompella and A P Srinivas, Virinchi Limited is an IT Products Services company offering customized solutions to companies across the globe since year 1990. Company pioneered the investment in data science techniques to analyze clinical outcomes, leading as an initiative into healthcare business. The Company operates healthcare facilities in Banjara Hills, Barkatpura, and Hayathnagar in Hyderabad. It also manages two offshore IT development centers in Hyderabad (Banjara Hills and Hakimpet) and an onshore facility in Marlboro, New Jersey, USA. Virinchi has developed retained IP in several software products operating in supply chain management, alternate financial services, however, has had limited success in offering most of the solutions barring the software product for financial services where Virinchi has reached leadership position considering the market share of this niche industry.Company has developed retained IP in several software products operating in supply chain management, alternate financial services, however, has had limited success in offering most of the solutions barring the software product for financial services where Virinchi has reached leadership position considering the market share of this niche industry. The Organisation is led by First Generation IIT/IIM Entrepreneurs and operates out of its Corporate Office at Banjara Hills, Hyderabad, India US Head Quarters at Marlboro, New Jersey. Virinchi had set up a software development centre at Hyderabad and develop and market webbased applications. The total project cost was Rs 22.95 cr and was financed through promoters (Rs 15.25 cr), the public(Rs 5.70 cr) and the rest Rs 2 cr by way of debt. The company had set up marketing and development centres in the US and Malaysia.Virinchi Infrastructure Advisory Sdn. Bhd. is an advisory service company of Virinchi in Malaysia. It offers services in the field of management consulting and corporate diverification for Malaysian companies. It has signed an agreement with Kulim Technology Management Sdn. Bhd., Malaysia, to market its services and to develop software technology parks in India.Virinchi has many domestic and foreign alliances for identifying projects, arrangement of foreign equity, technical and marketing support and for providing project finance in India for core and infrastructure projects.The Company acquired 100% Shareholding of Ksoft Systems Inc which became effective from 19th October, 2006. It set up a new International Data Centre (IDC) in Santa Clara, CA, USA in 2016. During 201617, the amalgamation of M/s. Bristlecone Hospitals Private Ltd with the Company was implemented and made effective from 01st April,2016. The Company launched a modern flagship health care facility in Hyderabad (Banjara Hills) comprising 350 beds in November, 2016 (upgraded to 400 beds).During the year 201819, the Company sold its Healthcare Business to M/s. Virinchi Health Care Private Limited (VHPL), a Wholly Owned Subsidiary of the Company through the slump sale for a consideration of Rs 45.57 Crores. The Company introduced its Payment Credit Services division in India, providing partner financial institutions with its Fintech platform, vCard in 2019. Company incorporated two subsidiaries namely V23 Medical solutions Private Limited and Virinchi Capital Private Limited to carry on the new initiatives of the company during 202021 and became 100% subsidiaries of the Company. Thereafter, the Company acquired a new technology called Thromboelastrogram (TEG) which tracks the dynamics or sequence of clot development in a human body. It launched an assisted reproduction technique Invitro fertilisation (IVS) clinic headed by one of the most qualified specialists in Telangana. The brownfield asset light hospital was commissioned within 14 months at a capital cost of only Rs.0.45 Crores per bed.The Company started work on Clinical Decision Support System to augment doctor decision similarity model development gathering and analysis of clinical and diagnostic data of a large number of patients over multiple parameters in FY24.

For the full year FY2025–2026, revenue reached ₹308.3 crore and profit touched at ₹0.48 crore.

As of 21 Jan 2026, Virinchi share price is ₹20.2. The stock opened at ₹20.9 and had closed at ₹20.2 the previous day. During today’s trading session, Virinchi share price moved between ₹19.28 and ₹20.84, with an average price for the day of ₹20.06. Over the last 52 weeks, the stock has recorded a low of ₹19.28 and a high of ₹32.69. In terms of performance, Virinchi share price has declined by 31.4% over the past six months and has declined by 34.13% over the last year.